)
World
Archived — This article has been archived. The information may be outdated.
Oxford trial injects first Ebola vaccine dose
NDTV··25 Jul
The first dose of ChAdOx1 BDBV Ebola vaccine went to 37-year-old Ed Hunt in Oxford on Friday. The shot targets the Bundibugyo strain killing over 1000 people in DRC and Uganda since May. Serum Institute stockpiled 620000 doses for a Phase 1 trial on 50 adults. The first dose went to 37-year-old Ed Hunt in Oxford on Friday.
Prism
What It Means For You
- The first ChAdOx1 BDBV dose went to 37-year-old Ed Hunt in Oxford on Friday.
- The vaccine targets Bundibugyo Ebola strain killing over 1000 in DRC and Uganda since May.
- Serum Institute stockpiled 620000 doses for a Phase 1 trial on 50 adults.
What's Happening
- Oxford researchers injected the first volunteer with a new Bundibugyo Ebola vaccine.
- ChAdOx1 BDBV was developed with Serum Institute backing amid a deadly regional outbreak.
- Phase 1 will test 50 adults while over 1000 deaths mount in Congo and Uganda.
Bundibugyo Strain Trial Begins
- Bundibugyo strain lacks approved vaccines unlike better-known Zaire Ebola tools.
- Serum Institute stockpile signals readiness for rapid scale-up if trials succeed.
- Oxford's ChAdOx platform previously accelerated COVID vaccine development timelines.
all-newstop-stories
